EL PASO, Texas (KTSM) — More and more Americans are turning to GLP-1 medications for weight loss. Their popularity is increasing in El Paso as well.
About 11 percent of U.S. adults (roughly 28 million Americans) are currently taking GLP-1 medications like Ozempic, Wegovy, or Mounjaro, with 15 percent reporting they have used them at some point. The rate has quadrupled from just 3 percent in 2024, per polling from the Gallup News Poll.
Dr. Benjamin Clapp, a board certified bariatric surgeon and Medical Director for The Hospitals of Providence Weight Loss Center, joined KTSM 9 News Anchor Andy Morgan live at 6:30 p.m. on Tuesday, July 21, to talk about the rising popularity of GLP-1 medications for weight loss. Dr. Clapp also discussed the risks associated with the drug, as well as its side effects and effectiveness…